Myriad Genetics to Participate in Stephens Annual Investment Conference
2023年11月9日 - 9:00PM
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
and precision medicine, today announced Myriad management will
participate in the Stephens Annual Investment Conference in
Nashville, TN with a fireside chat on Wednesday, November 15 at
2:00 p.m. ET.
A live and archived webcast of the presentation can
be viewed in the investor relations section of Myriad’s website at
www.myriad.com.
About Myriad GeneticsMyriad Genetics is a
leading genetic testing and precision medicine company dedicated to
advancing health and well-being for all. Myriad develops and offers
genetic tests that help assess the risk of developing disease or
disease progression and guide treatment decisions across medical
specialties where genetic insights can significantly improve
patient care and lower healthcare costs. For more information,
visit www.myriad.com.
| Media
Contact: |
Investor Contact: |
| Glenn Farrell |
Matt Scalo |
| (385) 318-3718 |
(801) 584-3532 |
| PR@myriad.com |
IR@myriad.com |
Myriad Genetics (NASDAQ:MYGN)
過去 株価チャート
から 4 2024 まで 5 2024
Myriad Genetics (NASDAQ:MYGN)
過去 株価チャート
から 5 2023 まで 5 2024
